Research and development

East Sussex Healthcare NHS Trust is conducting over seventy clinical research studies and research activity is increasing, demonstrating our commitment to improving the quality of care we offer and to making our contribution to wider health improvement.

The Trust currently supports research activity within several clinical fields including:

  • Oncology
  • Cardiology
  • Stroke
  • Elderly Care
  • Paediatrics
  • Orthopaedics
  • Dermatology
  • Diabetes and Endocrinology
  • Rheumatology
  • Community studies

This activity is supported by a dedicated Research and Development (R&D) department comprising: R&D Clinical Lead, R&D Manager, Research Governance Officer, Research Administrator and accountant. This team works closely with Principal Investigators (PI’s) research nurses, Allied Health Professionals and data officers involved in conducting research studies.

The R&D team are responsible for ensuring all appropriate research governance checks have been conducted to maintain research quality and provide safeguards to the public. In collaboration with divisional leads, NHS permissions are granted prior to commencement of any research undertaken.

Operational capability statement

The Department of Health expects NHS organisations to publish an operational capability statement (OCS).

NHS organisations that do so make a clear statement about what they are able to offer as hosts or sponsors of health research. Sponsors and researchers can see and use the information to inform and speed up decisions about where to carry out research.

Through the development of the OCS, East Sussex Healthcare NHS Trust have demonstrated that health research is a core activity within the organisation.

Performance in initiating and delivering clinical research

All NHS organisations are required to publish information on clinical trials.

The two key measures, for research studies or clinical trials we are involved in are:

  1. How rapidly the first participant is involved in a trial after the trial has been submitted for approval, for all types of trial regardless of funder. The Government-set target is 70 days, and there must be valid reasons for any trial exceeding this.
  2. How we are doing at involving people in our current trials with commercial sponsors, and how many of our trials have involved the full number of participants we said they would, within the time we said they would.

More information

For more information contact:

Liz Still
Research Support Manager

(01323) 417400 Ext: 3880 / 3042